期刊文献+

用于减肥的新型药物Contrave 被引量:1

A drug used for weight loss: Contrave
下载PDF
导出
摘要 Contrave是FDA新批准的用于肥胖患者减肥的口服缓释药物,是由2种药物成分纳曲酮和安非他酮组合而成,每片包含盐酸纳曲酮8 mg、盐酸安非他酮90 mg,2者合用对激动阿片促黑激素皮质素原(pro-opiomelanocortin,POMC)神经元具有互补和协同效应,能显著减轻肥胖患者体质量,并且无严重不良事件报道。本文对Contrave的临床前研究、临床试验、药代动力学以及不良反应等方面作一综述。 Contrave is approved by FDA as an oral extended-release drug used in obese patients' weight loss. Each tablet contains 8 mg of naltrexone hydrochloride and 90 mg of bupropion hydrochloride. And BUP + NAL stimulated hypothalamic pro-opiomelanocortin( POMC) neurons with a complementary and synergy effect. Contrave could reduce obese patients' body weight and has no serious adverse events. Contrave preclinical studies,clinical research,pharmacokinetics characteristics,adverse reactions are summaried in the article.
出处 《中国生化药物杂志》 CAS 2016年第1期183-185,共3页 Chinese Journal of Biochemical Pharmaceutics
关键词 Contrave 肥胖 临床前研究 临床试验 药代动力学 不良反应 Contrave obesity preclinical studies clinical trail pharmacokinetics characteristics adverse reactions
  • 相关文献

参考文献26

  • 1Early J, Whitten JS. Naltrexone/Buproprion ( Contrave ) for weight loss[ J]. Am Faro Physician,2015,91 (8) :554.
  • 2Yanovski SZ, Yanovski JA. Nahrexone Extended-Release Plus Bupropion Extended-Release for Treatment of Obesity [ J ]. JAMA, 2015,313(12) :1213-1214.
  • 3赵宪荣,董进和,孙兆荣,武夏明,史桂云.纳曲酮的神经精神药理作用及其临床应用[J].社区医学杂志,2004,2(1):32-34. 被引量:1
  • 4李君.安非他酮应用与精神分裂症病人戒烟的疗效分析[D].济南:山东大学.
  • 5Greenway FL, Whitehouse M J, Guttadauria M, et al. Rational design of a combination medication for the treatment of obesity[ J]. Obesity,2009, 17( 1 ) :30-39.
  • 6张志岐,束刚,江青艳.下丘脑对脂类的营养感应及其参与食欲调控的机制[J].动物营养学报,2013,25(7):1395-1405. 被引量:6
  • 7Orexigen Therapeutics Inc. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Nahrexone Sustained Release (SR) UsedinContrave(R). www. orexigen, corn,06 Oct 2008 Media Release.
  • 8Fleming GA. Regulatory Considerations for Early Clinical Development of Drugs for Diabetes, Obesity, and Cardiometabolic Disorders [ M ]// Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development. Springer London,2015:283-304.
  • 9George M, Rajaram M, Shanmugam E. New and emerging drug molecules against obesity [ J ]. J Cardiovasc Pharmacol Ther, 2014,19 (1) :65-76.
  • 10Roh E, Kim MS. New and emerging drugs for the treatment of obesity[ J]. J Korean Med Assoc,2015,58(5 ) :452-457.

二级参考文献5

共引文献5

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部